PGEN - Company ID 0001356090
The table below shows PRECIGEN, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$43.83M | -$16.32M | -$14.09M | -$18.39M | -$18.78M | -$16.38M |
| Capital expenditure | $258.00K | $622.00K | $4.35M | $154.00K | $1.58M | $1.01M |
| Investing cash flow | $20.97M | -$6.46M | $24.05M | -$50.41M | $16.57M | -$129.10M |
| Dividends paid | - | - | - |
PRECIGEN, INC. reported operating cash flow of -$87.83M for fiscal year 2025. That is down 28.8% from -$68.17M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$48.99M (FY 2016) to -$87.83M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $109.00K | -$679.00K | $0.00 | $44.17M | -$163.00K | $121.04M |